AU3791899A - (2-acylaminothiazole-4-yl)acetic acid derivatives - Google Patents

(2-acylaminothiazole-4-yl)acetic acid derivatives

Info

Publication number
AU3791899A
AU3791899A AU37918/99A AU3791899A AU3791899A AU 3791899 A AU3791899 A AU 3791899A AU 37918/99 A AU37918/99 A AU 37918/99A AU 3791899 A AU3791899 A AU 3791899A AU 3791899 A AU3791899 A AU 3791899A
Authority
AU
Australia
Prior art keywords
acylaminothiazole
acetic acid
acid derivatives
derivatives
acetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37918/99A
Inventor
Kenneth Lewis Kees
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU3791899A publication Critical patent/AU3791899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AU37918/99A 1998-05-12 1999-05-10 (2-acylaminothiazole-4-yl)acetic acid derivatives Abandoned AU3791899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7670898A 1998-05-12 1998-05-12
US09076708 1998-05-12
PCT/US1999/010212 WO1999058514A1 (en) 1998-05-12 1999-05-10 (2-acylaminothiazole-4-yl)acetic acid derivatives

Publications (1)

Publication Number Publication Date
AU3791899A true AU3791899A (en) 1999-11-29

Family

ID=22133723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37918/99A Abandoned AU3791899A (en) 1998-05-12 1999-05-10 (2-acylaminothiazole-4-yl)acetic acid derivatives

Country Status (6)

Country Link
EP (1) EP1077960A1 (en)
JP (1) JP2002514633A (en)
CN (1) CN1308619A (en)
AU (1) AU3791899A (en)
CA (1) CA2330558A1 (en)
WO (1) WO1999058514A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1331327A (en) * 2000-06-26 2002-01-16 上海博德基因开发有限公司 Polypeptide-human striatum-enriched phosphatase 14.85 and polynucleotide for coding it
AU2002349705A1 (en) 2001-12-03 2003-06-17 Japan Tobacco Inc. Azole compound and medicinal use thereof
CA2521830A1 (en) * 2003-04-09 2004-10-21 Japan Tobacco Inc. Heteroaromatic pentacyclic compound and medicinal use thereof
ATE384526T1 (en) * 2003-04-14 2008-02-15 Inst For Pharm Discovery Inc N-(((((1,3-THIAZOL-2-YL)AMINO)CARBONYL)PHENYL)SULPHONYL)PHENYLALANINE DERIVATIVES AND RELATED COMPOUNDS FOR THE TREATMENT OF DIABETES
AU2004236173B2 (en) 2003-04-30 2008-07-03 The Institutes For Pharmaceutical Discovery, Llc Substituted carboxylic acids
US7141596B2 (en) 2003-10-08 2006-11-28 Incyte Corporation Inhibitors of proteins that bind phosphorylated molecules
AU2005236055B2 (en) 2004-04-20 2011-10-06 Transtech Pharma, Llc Substituted thiazole and pyrimidine derivatives as melanocortin receptor modulators
CN101260086B (en) * 2007-03-06 2011-08-10 中国科学院上海药物研究所 Protein-tyrosine-phosphatase 1B inhibitor and its preparation method and use
CA2731442A1 (en) 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
CN102408417B (en) * 2011-09-26 2015-03-11 上海交通大学 2-substituted vinylsulfonate compound and preparation method and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996016650A1 (en) * 1994-11-29 1996-06-06 Hisamitsu Pharmaceutical Co., Inc. Antibacterial or bactericide comprising 2-aminothiazole derivative and salts thereof
US5688821A (en) * 1995-12-12 1997-11-18 American Home Products Corporation Unsaturated fatty acyl derivatives of 2-aminothiazoleacetic acid and their salts as inhibitors of phospholipase A2 derived from human sources
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use

Also Published As

Publication number Publication date
CA2330558A1 (en) 1999-11-18
CN1308619A (en) 2001-08-15
JP2002514633A (en) 2002-05-21
WO1999058514A1 (en) 1999-11-18
EP1077960A1 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
AU2776197A (en) Alkoxy acetic acid derivatives
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU1177300A (en) Thiocarbamic acid derivatives
AU1559199A (en) Isothiazolcarboxylic acid derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU1379900A (en) Novel substituted phenyloxazolidone derivatives
AU1268400A (en) Isothiazolecarboxylic acid derivatives
AU7940598A (en) Quinolone carboxylic acid derivatives
AU3791899A (en) (2-acylaminothiazole-4-yl)acetic acid derivatives
AU3093697A (en) Aminophthalic acid derivatives
AU3443897A (en) Glyoxylic acid derivatives
AU1303201A (en) Alkoxyiminoalkanoic acid derivatives
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU4547896A (en) 4-oxo-2-butenoic acid derivatives
AU5289299A (en) Divinylstilbenesulfonic acid derivatives
AU2690600A (en) 2-mercaptocarboxylic acid derivatives
AU2640999A (en) 1-azaindolizine derivatives
AU6262300A (en) Indolinylamide derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU5191199A (en) Fatty acid derivatives
AU5239899A (en) Amidophosphate derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives
AU2894099A (en) Phenanthrofuran derivatives
AU5666800A (en) Difuropyrone derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase